Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop

National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Health and Medicine Division; U.S. Science and Innovation Policy; Board on Population Health and Public Health Practice; Board on Health Sciences Policy; Roundtable on Black Men and Black Women in Science, Engineering, and Medicine; Forum on Drug Discovery, Development, and Translation.
Free Books & Documents

Excerpt

Despite advances over the past several decades, the clinical trials enterprise has struggled to meet the needs of an increasingly diverse U.S. population. To help address this issue, a 2023 National Academies workshop sought to identify the expertise and disciplines needed to achieve the aspirations for a transformed clinical trials enterprise by 2030 and enable a workforce that can better support the evolving needs of drug R&D - one that is resilient, culturally aware, anti-racist, and interdisciplinary. The workshop, hosted by the Forum on Drug Discovery, Development, and Translation and Roundtable on Black Men and Black Women in Science, Engineering, and Medicine explored strategies to bolster workforce capacity and challenges and opportunities associated with supporting the next-generation drug R&D workforce.

PubMed Disclaimer

Grants and funding

This activity was supported by contracts between the National Academy of Sciences and Aetna Foundation (Contract No. 18-8876); Amgen Inc.; Association of American Medical Colleges; AstraZeneca; Biogen; Burroughs Wellcome Fund (Contract No. 1023129); Chan Zuckerberg Initiative; Critical Path Institute; Eli Lilly and Company; FasterCures, Milken Institute; Foundation for the National Institutes of Health; Friends of Cancer Research; Johnson & Johnson; Medable Inc.; Merck & Co., Inc. (Award No. MRLCPO-23-166623); National Research Council President’s Circle Fund; National Institutes of Health (Contract No. HHSN263201800029I; Task Order No. HHSN26300007, 75N98021F00006): National Cancer Institute, National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Office of the Director; New England Journal of Medicine; Robert Woods Johnson Foundation; Sanofi (Contract No. 77646387); Takeda; The University of Pittsburgh; U.S. Food and Drug Administration (Contract No. 1R13FD007302-01); W.K. Kellogg Foundation. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

LinkOut - more resources